BioSpace News Archive

Job Trends

US Biopharma Company Undertakes Anti-Cancer Clinical Trials in Poland, First Patient Showing Positive Initial Treatment - April 29, 2019

Moleculin quickly recruited qualified patients and started trials for two of its portfolio drugs to supplement US efforts.

April 29, 2019
·
6 min read
First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study

Christian Lattermann, M.D., Chief of the Sports Medicine Service and Director of the Center for Cartilage Repair at Brigham and Women’s Hospital in Boston, recently became the first surgeon in New England to enroll a patient in CartiHeal’s FDA – IDE study.

April 29, 2019
·
1 min read
Deals

OTC Markets Group Welcomes Beroni Group Ltd. to OTCQX

OTC Markets Group Inc. announced Beroni Group Ltd., an international biotechnological company, has qualified to trade on the OTCQX® Best Market.

April 29, 2019
·
3 min read
FDA

Finch Therapeutics Receives Fast Track Designation for the Investigation of Full-Spectrum Microbiota as a Treatment for Children with Autism Spectrum Disorder

Finch Therapeutics Group, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation to its Full-Spectrum Microbiota® therapy for the treatment of children with Autism Spectrum Disorder.

April 29, 2019
·
3 min read
Business

Concert Pharmaceuticals Names Jesper Høiland to its Board of Directors

Concert Pharmaceuticals, Inc. announced that Jesper Høiland has been appointed to its Board of Directors and will serve as a member of its Compensation Committee, effective immediately.

April 29, 2019
·
2 min read
Deals

Charles River Laboratories Completes the Acquisition of Citoxlab

Charles River Laboratories International, Inc. announced that it has completed the previously announced acquisition of Citoxlab for €448 million in cash, subject to customary closing adjustments.

April 29, 2019
·
3 min read
BioMidwest

FirstLight Home Care Honors Franchisees at Annual Conference in Kansas City

Leading non-medical home care provider offers training, seminars and awards during three-day event

April 29, 2019
·
3 min read
Policy

ViiV Healthcare Submits New Drug Application to US FDA for the First Monthly, Injectable, Two-Drug Regimen of Cabotegravir and Rilpivirine for Treatment of HIV

If approved, cabotegravir and rilpivirine would be the first-ever long-acting, injectable treatment regimen for adults living with HIV

April 29, 2019
·
12 min read
BioCapital

Intrexon and Xogenex Present at American Society of Gene and Cell Therapy Annual Meeting

Intrexon Corporation and its majority owned Intrexon Health subsidiary Xogenex, announced that four abstracts will be presented as posters at the American Society of Gene and Cell Therapy Annual Meeting, which will be held April 29 - May 2, 2019, at the Washington Hilton in Washington, D.C.

April 29, 2019
·
4 min read
New York Hemp Industrial Park Update

Canopy Growth will transform the building this summer in Kirkwood, NY for previously announced Hemp Industrial Park

April 29, 2019
·
7 min read